PLSE FY 2021 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

FY 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1M

Gross Profit

-$550,000-38.8% margin

Operating Income

-$63M-4443.9% margin

Net Income

-$64M-4489.4% margin

EPS (Diluted)

$-2.28

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$54M

Total Liabilities

$19M

Stockholders' Equity

$36M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	-$550,000	-$1M	+49.8%
Operating Income	-$63M	-$50M	-26.1%
Net Income	-$64M	-$50M	-28.0%